Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chailian Cold Granules for Acute Upper Respiratory Infection (Wind-Heat Syndrome)
CTR20171349Phase 2Completed
- Sponsor
- Wuhan Shuanglong Pharmaceutical
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chailian ganmao granules in upper respiratory infection (URI), sponsored by Wuhan Shuanglong Pharmaceutical. Started Nov 2017; status: completed.
02
Drugs
chailian ganmao granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20171349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171349.